Latest Content

Explore the vital role of consultation liaison psychiatry in enhancing patient care and emotional well-being in complex medical conditions in our January 2026 theme!

Xanomeline/trospium emerges as a groundbreaking schizophrenia treatment, showcasing efficacy and safety while highlighting challenges in clinical adoption.

MapLight Therapeutics advances treatment for Alzheimer disease psychosis with FDA Fast Track designation for ML-007C-MA, targeting hallucinations and delusions.

Integrating arts and humanities into psychiatry enhances patient recovery, fosters connectedness, and enriches clinician engagement, transforming mental health care.

Psychiatry explores the complex interplay between obesity and mental health, advocating for integrated care to enhance treatment outcomes and reduce stigma.

Read part 1 of our lifestyle psychiatry special report, all in one place!

Biohaven's BHV-7000 fails to reduce depressive symptoms in a phase 2 proof-of-concept study.

Clinicians can guide patients with bipolar disorder in setting flexible, achievable New Year’s goals, enhancing motivation and stability throughout mood fluctuations.

What disease states are most prominently featured in recent research? Learn more in this exclusive article.

Check out the pipeline updates from December!

OpenAI's shift from a nonprofit to a profit-driven entity raises concerns about user safety and ethical AI development amidst psychological consequences.

Discover groundbreaking findings on digital therapeutics and medications for schizophrenia and depression, showcasing safety and efficacy in recent studies.